Rovenský J, Tuchyňová A. Systemic lupus erythematosus in the elderly. Autoimmun Rev. 2008;7:235–9.

PubMed  Google Scholar 

Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol. 2012;39:759–69.

PubMed  PubMed Central  Google Scholar 

Urrestarazú A, Otatti G, Silvariño R, Garau M, Coitiño R, Alvarez A, Gonzalez E, Gadola L, Praga M, Noboa O. Lupus nephritis in males: clinical features, course, and prognostic factors for end-stage renal disease. Kidney Int Rep. 2017;2:905–12.

PubMed  PubMed Central  Google Scholar 

Hoover PJ, Costenbader KH. Insights into the epidemiology and management of lupus nephritis from the US rheumatologist’s perspective. Kidney Int. 2016;90:487–92.

PubMed  PubMed Central  Google Scholar 

Tektonidou MG, Abhijit D, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and bayesian meta-analysis. Arthritis Rheumatol. 2016;68:1432–41.

PubMed  PubMed Central  Google Scholar 

Fogo AB, Lusco MA, Behzad N, Alpers CE. AJKD atlas of renal pathology: focal and diffuse lupus nephritis (ISN/RPS Class III and IV). Am J Kidney Dis. 2017;70:e9–11.

PubMed  Google Scholar 

Larsen CP, Boils CL, Cossey LN, Sharma SG, Walker PD. Clinicopathologic features of membranous-like glomerulopathy with masked IgG kappa deposits. Kidney Int Rep. 2016;1:299–305.

CAS  PubMed  PubMed Central  Google Scholar 

Nasr SH, Galgano SJ, Markowitz GS, Stokes MB, D’Agati VD. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70:2148–51.

CAS  PubMed  Google Scholar 

Yamazaki T, Takahashi H, Takeuchi K, Sakamoto E, Tominaga K, Sakurabayashi S, Abe T, Sano T, Wada Y, Kuwahara N, Shimizu A, Takeuchi Y. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report. BMC Nephrol. 2023;24:218.

CAS  PubMed  PubMed Central  Google Scholar 

Kenta T, Etsuko T, Kazuhiro T, Shoichiro T, Emi S, Hideaki K, Yusuke K, Yasuhiro T, Shinobu K, Mika T, Hiroyasu G, Toshihiko I, Naoki O, Akira S. Myeloperoxidase-associated membranous nephropathy in antineutrophil cytoplasmic antibody-associated glomerulonephritis. Kidney Int Rep. 2024;9:2240–9.

Google Scholar 

Sethi S. New ‘Antigens’ in membranous nephropathy. J Am Soc Nephrol. 2021;32:268–78.

CAS  PubMed  Google Scholar 

Farah AL, Tiffany C, Claire T-A, Rodan AR, Nicole A, Norifumi H, Brandi W, Revelo MP, Fred C, Jo A, Edwin L, Willisa L, Chang-Jiang Z, Nirupama R, Tim C, Wilkey DW, Issa K, Christian H, Aaron S, Rick E, Ronald S, Tianxin Y, Jeremy C, Michael M, John A, Jon K, Chris L, Jr Beck LH. Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy. J Am Soc Nephrol. 2021;32:1666–81.

Google Scholar 

Larsen CP, Ambuzs JM, Bonsib SM, Boils CL, Nicholas CL, Messias NC, Silva FG, Wang YH, Neriman G, Walker PD. Membranous-like glomerulopathy with masked IgG kappa deposits. Kidney Int. 2014;86:154–61.

CAS  PubMed  Google Scholar 

Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D’Agati VD. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int. 2004;65:85–96.

CAS  PubMed  Google Scholar 

Nagahama K, Isomura A, Shimoyamada H, Masuko S, Shimoda S, Karube M, Komagata Y, Kaname S, Shibahara J. Membranous nephropathy with masked polyclonal IgG deposits associated with primary Sjögren’s syndrome. CEN Case Rep. 2021;10:53–8.

PubMed  Google Scholar 

Larsen CP, Messias NC, Walker PD, Fidler ME, Cornell LD, Hernandez LH, Alexander MP, Sethi S, Nasr SH. Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int. 2015;88:867–73.

CAS  PubMed  PubMed Central  Google Scholar 

Wenbin L, Guangrui H, Hongliang R, Geng Jie Hu, Haikun HY, Guiyang H, Baoli L, Anlong X. Course monitoring of membranous nephropathy: both autoantibodies and podocytes require multidimensional attention. Autoimmun Rev. 2022;21:102976.

Google Scholar 

Corrado M, Maurizio B, Sonia S, Xhuliana K, Verrina Enrico E, Andrea A, Gianluca C, Giovanni C, Sandro F, Marco P, Marco GG. Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond. Clin Kidney J. 2023;17:228.

Google Scholar 

Barber MRW, Hanly JG, Su L, Urowitz MB, St PY, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Fortin PR, Gladman DD, Sanchez-Guerrero J, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V, Clarke AE. Economic evaluation of lupus nephritis in the systemic lupus international collaborating clinics inception cohort using a multistate model approach. Arthritis Care Res (Hoboken). 2018;70:1294–302.

PubMed  Google Scholar 

Li S, Luo Q, Fan Y, Zhao C, Huang F, Xia X, Chen W. Clinicopathological characteristics and prognosis of lupus nephritis patients with acute kidney injury. Am J Nephrol. 2023;54:536–45.

CAS  PubMed  Google Scholar 

Fangfang S, Huijing W, Danting Z, Fei H, Shuang Ye. One-year renal outcome in lupus nephritis patients with acute kidney injury: a nomogram model. Rheumatology. 2021;61:2886–93.

Google Scholar